A 5-minute summary of an observational study investigating how glucose control affected the immune response to COVID-19 vaccination, published in Diabetes, Obesity & Metabolism. Listen for a quick overview of the key findings.

Publication: Marfella R, et al. Does poor glycaemic control affect the immunogenicity of the COVID-19 vaccination in patients with type 2 diabetes: The CAVEAT study. Diabetes Obes Metab. 2021 Sep 8. doi: 10.1111/dom.14547. Epub ahead of print.

Additional references: Rawshani A, et al. Severe COVID-19 in people with type 1 and type 2 diabetes in Sweden: A nationwide retrospective cohort study. Lancet Reg Health Eur. 2021 May;4:100105. doi: 10.1016/j.lanepe.2021.100105. Epub 2021 Apr 30.

For more free education, visit the DKIP website, follow us on Twitter (@dkipractice) or connect on LinkedIn. 

Target Audience

This educational activity is intended for an international audience of non-US and non-UK HCPs.

Funding statement:

This independent educational activity is supported by an educational grant from Novo Nordisk A/S. The educational content has been developed by Liberum IME in conjunction with an independent steering committee; Novo Nordisk A/S has had no influence on the content of this education.